Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Gets $10.5M Financing for RNA Research

NEW YORK, May 1 - RNA provider Ambion has raised $10.5 million in a private financing, the company said today.


The financing was led by VC firm Telegraph Hill Partners, of San Francisco. Consequently, Ambion has appointed J. Matthew Mackowski of Telegraph Hill to its Board of Directors.


The company is planning to use the financing to grow its business in RNA research, including clinical applications of RNA, Ambion CEO Matt Winkler said in a statement.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.